Condition: Gastric Cancer · Sponsor: Shanghai Minimally Invasive Surgery Center
This prospective clinical observational study aims to construct a metabolite database specifically for gastric cancer patients using metabolomics technology. It seeks to develop and validate metabolic biomarkers for early diagnosis, prognosis, and prediction of recurrence and metastasis in gastric cancer, thereby a establishing safe, convenient, and highly sensitive method for early screening and prognostic prediction.
This description comes directly from the study's public registry record.
Jing Sun · +86-13524284622 · sj117788@rjh.com.cn
Always discuss trial participation with your own doctor first.
| Ruijin hospital Shanghai Jiaotong University, School of Medicine , Shanghai, Shanghai 200025 | Shanghai, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07076979